| P50 | author | Robert Kypta | Q42175104 |
| | Miguel Unda | Q57415953 |
| P2093 | author name string | Arkaitz Carracedo | |
| P2860 | cites work | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 |
| | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression | Q24654019 |
| | Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis | Q24681977 |
| | Pten dose dictates cancer progression in the prostate | Q24791909 |
| | MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors | Q27350187 |
| | Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 |
| | Molecular portraits of human breast tumours | Q28032461 |
| | Molecular mechanisms of cancer development in obesity | Q28253823 |
| | Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells | Q28479062 |
| | Pten is essential for embryonic development and tumour suppression | Q28509238 |
| | Abiraterone and increased survival in metastatic prostate cancer | Q29617512 |
| | A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis | Q33685619 |
| | The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature | Q34065526 |
| | Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours | Q34095870 |
| | Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. | Q34155557 |
| | Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth | Q35168294 |
| | Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants | Q35249697 |
| | Molecular classification of prostate cancer using curated expression signatures | Q35641563 |
| | Oncogene addiction | Q37152445 |
| | Tenets of PTEN tumor suppression | Q37154214 |
| | Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy | Q37170452 |
| | Quality of life associated with treatment of castration-resistant prostate cancer: a review of the literature | Q37974971 |
| | Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate | Q39506775 |
| | The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis | Q39538459 |
| | Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer | Q39541646 |
| | Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis | Q41778982 |
| | ETS rearrangements and prostate cancer initiation | Q42391765 |
| | Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers | Q42455712 |
| | BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles | Q42477700 |
| | Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8. | Q42942330 |
| | Myc-driven murine prostate cancer shares molecular features with human prostate tumors | Q45049671 |
| | Common structural and epigenetic changes in the genome of castration-resistant prostate cancer | Q46109205 |
| | Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes | Q57660183 |
| | Obesity and cancer | Q57748968 |
| | Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer | Q58068307 |
| | Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization | Q73023220 |
| | Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization | Q73919482 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 53 | |
| P577 | publication date | 2012-04-12 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Is the bench getting closer to the bedside in the war on cancer? A quick look at prostate cancer | |
| P478 | volume | 3 | |